MEDINCELL - Trademark Details
Status: 700 - Registered
Serial Number
88404359
Registration Number
6077767
Word Mark
MEDINCELL
Status
700 - Registered
Status Date
2020-06-16
Filing Date
2019-04-26
Registration Number
6077767
Registration Date
2020-06-16
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-03-31
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
IM, JEAN H
Statements
Goods and Services
Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-05-13
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (société anonyme (sa)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (société anonyme (sa)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (société anonyme (sa)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (société anonyme (sa)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Stephen P. McNamara
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2018-10-29 | 017976013 | EM | True |
Trademark Events
| Event Date | Event Description |
| 2019-04-30 | NEW APPLICATION ENTERED IN TRAM |
| 2019-05-13 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-05-13 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 2019-05-19 | ASSIGNED TO LIE |
| 2019-05-23 | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED |
| 2019-07-09 | ASSIGNED TO EXAMINER |
| 2019-07-10 | NON-FINAL ACTION WRITTEN |
| 2019-07-10 | NON-FINAL ACTION E-MAILED |
| 2019-07-10 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-01-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-01-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-01-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-01-31 | EXAMINERS AMENDMENT -WRITTEN |
| 2020-01-31 | EXAMINERS AMENDMENT E-MAILED |
| 2020-01-31 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2020-01-31 | EXAMINER'S AMENDMENT ENTERED |
| 2020-01-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-02-07 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 2020-02-27 | ELECTRONIC RECORD REVIEW COMPLETE |
| 2020-03-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2020-03-31 | PUBLISHED FOR OPPOSITION |
| 2020-03-31 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2020-06-16 | REGISTERED-PRINCIPAL REGISTER |
